US Senator Elizabeth Warren calls for a federal investigation into GSK and its discontinuation of Flovent HFA

Why scientists are looking to the microscopic marvel of the tardigrade for new approaches to cancer treatment.

From cybersecurity challenges and AI-driven decision-making, to making mundane tasks more skillful, robotics is reshaping pharmaceutical operations.

Experts explain why these are two important areas to watch in the near future of pharma R&D.

Celebrating the winner of our annual Innovation Awards: a service for co-crystal prediction.

Indian CDMO denies manufacturing drug, contract testing lab pulled up for deficiencies, and lessons learned from Sanofi’s warning letter.

Manufacturing bottlenecks remain a key hurdle in CAR-T therapy. Can automation and digital integration change that?

Purdue University’s Young Institute is tackling pharma’s toughest challenges— from mRNA stability to aseptic manufacturing.

We get the story behind the development of Spiroligomer molecules and how they can help drug the undruggable.

How antisense oligonucleotides open up targeted approaches to rare disease treatment.